The registry will combine the resources of lung cancer physicians and scientists worldwide by pooling millions of dollars worth of lung cancer research data in one location. Then, by organizing the data and making it accessible, the registry will dramatically increase the potential for development of new lifesaving treatments. By all accounts the registry’s return on investment should be remarkable and operational costs for the registry’s first five years are extremely modest – estimated at only $1,000,000.

Under the direction of Dr. Alex A. Adjei and Dr. Mary Reid, representatives from registry partner cancer centers, and Xillix Technologies Corp. meet regularly to guide, support, and promote use of the registry.